Login / Signup

Ocrelizumab shorter infusion: Primary results from the ENSEMBLE PLUS substudy in patients with MS.

Hans-Peter Hartungnull null
Published in: Neurology(R) neuroimmunology & neuroinflammation (2020)
NCT03085810.
Keyphrases
  • mass spectrometry
  • multiple sclerosis
  • ms ms
  • low dose
  • neural network
  • machine learning